The transmembrane protein tetraspanin 5 controls the effects of loss of the tumor suppressor deleted in liver cancer 1 (DLC1) on hepatocellular carcinoma (HCC) growth

Schreyer L, Mittermeier C, Martin DE, Singer S, Liebl B, Gudermann T, Aigner A, Mühlich S (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Naunyn-Schmiedeberg's Archives of Pharmacology Springer

Publisher: SPRINGER

City/Town: NEW YORK

Pages Range: S14-S14

Conference Proceedings Title: NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Authors with CRIS profile

Laura Schreyer Professur für Molekulare und Klinische Pharmazie Susanne Mühlich Professur für Molekulare und Klinische Pharmazie

Involved external institutions

National University of Singapore (NUS) SG Singapore (SG) Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Universitätsklinikum Tübingen DE Germany (DE) Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit (LGL) DE Germany (DE) Universität Leipzig DE Germany (DE)

How to cite

APA:

Schreyer, L., Mittermeier, C., Martin, D.E., Singer, S., Liebl, B., Gudermann, T.,... Mühlich, S. (2021). The transmembrane protein tetraspanin 5 controls the effects of loss of the tumor suppressor deleted in liver cancer 1 (DLC1) on hepatocellular carcinoma (HCC) growth. In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (pp. S14-S14). NEW YORK: SPRINGER.

MLA:

Schreyer, Laura, et al. "The transmembrane protein tetraspanin 5 controls the effects of loss of the tumor suppressor deleted in liver cancer 1 (DLC1) on hepatocellular carcinoma (HCC) growth." Proceedings of the NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY NEW YORK: SPRINGER, 2021. S14-S14.

BibTeX: Download